Talphera, Inc.
Pharmaceutical company · San Mateo, California, United States · Nasdaq: TLPH
Talphera, Inc. is a pharmaceutical company headquartered in San Mateo, California, United States. Its shares trade on Nasdaq under the ticker TLPH. It has reported private securities offerings to the US SEC, most recently $17 million sold in a notice filed in 2025.
Talphera at a glance
What does Talphera do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $17 million sold (2025).
Frequently asked questions about Talphera
Where is Talphera headquartered?
Talphera, Inc. is headquartered in San Mateo, California, United States.
What does Talphera do?
Talphera, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Talphera a public company?
Yes. Talphera, Inc. trades on Nasdaq under the ticker TLPH.
Similar companies
- Kronos Bio, Inc.San Mateo, California, United States
- NeurogesX IncSan Mateo, California, United States
- Vivace Therapeutics, Inc.San Mateo, California, United States
- Sierra Oncology, Inc.San Mateo, California, United States
- Talon Therapeutics, Inc.San Mateo, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences